Ehtesham Jameel

New Delhi, DL 110025, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Reinvestigation of diphenylmethylpiperazine analogues of pyrazine as new class of Plasmodial cysteine protease inhibitors for the treatment of malaria.

Reinvestigation of diphenylmethylpiperazine analogues of pyrazine as new class of Plasmodial cysteine protease inhibitors for the treatment of malaria.

Journal: RSC medicinal chemistry

Published: September 12, 2023

Identification of new oxospiro chromane quinoline-carboxylate antimalarials that arrest parasite growth at ring stage.

Identification of new oxospiro chromane quinoline-carboxylate antimalarials that arrest parasite growth at ring stage.

Journal: Journal of biomolecular structure & dynamics

Published: March 27, 2023

Recent advancements in chromone as a privileged scaffold towards the development of small molecules for neurodegenerative therapeutics.

Recent advancements in chromone as a privileged scaffold towards the development of small molecules for neurodegenerative therapeutics.

Journal: RSC medicinal chemistry

Published: December 25, 2021

Rational design, synthesis and biological screening of triazine-triazolopyrimidine hybrids as multitarget anti-Alzheimer agents.

Rational design, synthesis and biological screening of triazine-triazolopyrimidine hybrids as multitarget anti-Alzheimer agents.

Journal: European journal of medicinal chemistry

Published: January 26, 2017

De novo lead optimization of triazine derivatives identifies potent antimalarials.

De novo lead optimization of triazine derivatives identifies potent antimalarials.

Journal: Journal of molecular graphics & modelling

Published: August 31, 2016

Design, synthesis, and biological evaluation of pyrimidine derivatives as potential inhibitors of human calcium/calmodulin-dependent protein kinase IV.

Design, synthesis, and biological evaluation of pyrimidine derivatives as potential inhibitors of human calcium/calmodulin-dependent protein kinase IV.

Journal: Chemical biology & drug design

Published: August 22, 2016

Development of cyanopyridine-triazine hybrids as lead multitarget anti-Alzheimer agents.

Development of cyanopyridine-triazine hybrids as lead multitarget anti-Alzheimer agents.

Journal: Bioorganic & medicinal chemistry

Published: March 06, 2016

Synthesis and screening of triazolopyrimidine scaffold as multi-functional agents for Alzheimer's disease therapies.

Synthesis and screening of triazolopyrimidine scaffold as multi-functional agents for Alzheimer's disease therapies.

Journal: European journal of medicinal chemistry

Published: February 21, 2016

Structure guided design of potential inhibitors of human calcium-calmodulin dependent protein kinase IV containing pyrimidine scaffold.

Structure guided design of potential inhibitors of human calcium-calmodulin dependent protein kinase IV containing pyrimidine scaffold.

Journal: Bioorganic & medicinal chemistry letters

Published: September 04, 2015

Ferroquine and its derivatives: new generation of antimalarial agents.

Ferroquine and its derivatives: new generation of antimalarial agents.

Journal: European journal of medicinal chemistry

Published: May 18, 2015

Coumarin: A Privileged Scaffold for the Design and Development of Antineurodegenerative Agents.

Coumarin: A Privileged Scaffold for the Design and Development of Antineurodegenerative Agents.

Journal: Chemical biology & drug design

Published: May 07, 2015

Curcumin specifically binds to the human calcium-calmodulin-dependent protein kinase IV: fluorescence and molecular dynamics simulation studies.

Curcumin specifically binds to the human calcium-calmodulin-dependent protein kinase IV: fluorescence and molecular dynamics simulation studies.

Journal: Journal of biomolecular structure & dynamics

Published: May 02, 2015

Showing 1-12 of 12

Last Updated: 09/26/2026